PedAM
Pediatric Disease Annotations & Medicines
| Disease | multiple endocrine neoplasia |
| Phenotype | C0020502|hyperparathyroidism |
| Sentences | 16 |
| PubMedID- 24037737 | A 59-year-old woman with classic manifestations of hyperparathyroidism associated with multiple endocrine neoplasia type 1 presented with a right adrenal mass and two pituitary microadenomas on imaging studies. |
| PubMedID- 25262224 | A randomized, prospective trial of operative treatments for hyperparathyroidism in patients with multiple endocrine neoplasia type 1. |
| PubMedID- 22735224 | Objective: to evaluate frequency, anatomic presentation, and quantities of supernumerary parathyroids glands in patients with primary hyperparathyroidism (hpt1) associated with multiple endocrine neoplasia type 1 (men1), as well as the importance of thymectomy, and the benefits of localizing examinations for those glands. |
| PubMedID- 22584724 | Additionally, short-term and medium-term calcium and parathyroid hormone values after parathyroidectomy in patients with primary hyperparathyroidism associated with multiple endocrine neoplasia type 1 are discussed. |
| PubMedID- 22584718 | Conversely, hyperparathyroidism associated with multiple endocrine neoplasia type 1 (hyperparathyroidism/multiple endocrine neoplasia type 1) is an asynchronic, asymmetrical multiglandular disease and it is surgically approached by either subtotal parathyroidectomy or total parathyroidectomy followed by parathyroid auto-implant to the forearm. |
| PubMedID- 22584713 | Primary hyperparathyroidism associated with multiple endocrine neoplasia type i (hyperparathyroidism/multiple endocrine neoplasia type 1) differs in many aspects from sporadic hyperparathyroidism, which is the most frequently occurring form of hyperparathyroidism. |
| PubMedID- 22584719 | Primary hyperparathyroidism in multiple endocrine neoplasia type 1: when to perform surgery. |
| PubMedID- 19650788 | Bone mineral density analysis in patients with primary hyperparathyroidism associated with multiple endocrine neoplasia type 1 after total parathyroidectomy. |
| PubMedID- 23363383 | Also covered is the role of pharmacotherapy in controlling acid hypersecretion and other hormonal hypersecretory states these patients may develop, including hyperparathyroidism in patients with multiple endocrine neoplasia type 1 and zes; tumor localization; and the treatment of advanced metastatic disease. |
| PubMedID- 24581877 | [severe maintained hypocalcemia after parathyroidectomy for hyperparathyroidism in a patient with multiple endocrine neoplasia i and prior bariatric surgery]. |
| PubMedID- 21318141 | Primary hyperparathyroidism in patients with multiple endocrine neoplasia type 1. |
| PubMedID- 20431882 | Background: subtotal parathyroidectomy (sptx) is the treatment of choice for hyperparathyroidism in a patient with multiple endocrine neoplasia type 1 (hpt-men-1). |
| PubMedID- 22508712 | Results: we report two patients with primary hyperparathyroidism due to multiple endocrine neoplasia type 1 who had their first parathyroidectomy at the national institutes of health. |
| PubMedID- 20570815 | Evolution of surgical treatment of primary hyperparathyroidism in patients with multiple endocrine neoplasia type 2a. |
| PubMedID- 26031271 | Primary hyperparathyroidism in multiple endocrine neoplasia type i usually affects all parathyroid glands, making focused parathyroidectomy (fp) inappropriate. |
| PubMedID- 22281890 | Although hyperparathyroidism in multiple endocrine neoplasia 1 (men1) syndrome is the most common manifestation, parathyroid carcinoma is rare. |
Page: 1